Showing results (391-400 of 520) with videos related to
Sort By:
Pageof 52
The British Journal of Dermatology|August 24, 2021
Mogamulizumab efficacy is underscored by its associated rash that mimics cutaneous T-cell lymphoma: a retrospective single-centre case seriesN A Trum, J Zain, X U Martinez, et al.Cell Reports|October 28, 2024
CD84 as a therapeutic target for breaking immune tolerance in triple-negative breast cancerStav Rabani, Emine Gulsen Gunes, Martin Gunes, et al.Journal of Medicinal Chemistry|November 1, 1990
Synthesis, in vitro binding profile, and central nervous system penetrability of the highly potent 5-HT3 receptor antagonist [3H]-4-(2-methoxyphenyl)-2-[4(5)-methyl-5(4)-imidazolylmethyl]thiazoleT Rosen, T F Seeger, S McLean, et al.Journal of Medicinal Chemistry|October 1, 1990
Thiazole as a carbonyl bioisostere. A novel class of highly potent and selective 5-HT3 receptor antagonistsT Rosen, A A Nagel, J P Rizzi, et al.Cancer Biotherapy|January 1, 1993
A phase I escalating-dose safety, dosimetry and efficacy study of radiolabeled monoclonal antibody LYM-1T Kuzel, S T Rosen, A M Zimmer, et al.Biorxiv : the Preprint Server for Biology|February 17, 2023
MGA deletion leads to Richter's transformation via modulation of mitochondrial OXPHOSPrajish Iyer, Bo Zhang, Tingting Liu, et al.The Journal of Pharmacology and Experimental Therapeutics|October 1, 1993
Pharmacology of CP-99,994; a nonpeptide antagonist of the tachykinin neurokinin-1 receptorS McLean, A Ganong, P A Seymour, et al.Nucleic Acids Research|December 6, 2018
ITCH nuclear translocation and H1.2 polyubiquitination negatively regulate the DNA damage responseLufen Chang, Lei Shen, Hu Zhou, et al.Blood|November 1, 1983
Estrogen receptor analysis in chronic lymphocytic leukemiaS T Rosen, Z Maciorowski, F Wittlin, et al.Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1989
Immunohistochemical analysis of pulmonary and pleural tumors with the monoclonal antibody HYB-612 directed against the multidrug resistance (MDR-1) gene product, P-glycoproteinJ A Radosevich, P G Robinson, L S Rittmann-Grauer, et al.Pageof 52